HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemotherapy of malignant hemangiopericytoma.

Abstract
Thirty-nine chemotherapy trials in 16 patients with metastatic hemangiopericytoma treated at MSKCC and 33 trials from the literature are reviewed. Adriamycin, alone or in combination drug regimens, is the most effective agent, producing complete and partial remission in 50% of cases. Other drugs which show some activity include vincristine, cyclophosphamide, actinomycin, methotrexate and DTIC. The available data indicate malignant hemangiopericytoma should be considered chemotherapeutically responsive tumors.
AuthorsP P Wong, A Yagoda
JournalCancer (Cancer) Vol. 41 Issue 4 Pg. 1256-60 (Apr 1978) ISSN: 0008-543X [Print] United States
PMID346193 (Publication Type: Case Reports, Clinical Trial, Comparative Study, Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Doxorubicin
Topics
  • Adolescent
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Clinical Trials as Topic
  • Doxorubicin (therapeutic use)
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Hemangiopericytoma (drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis (drug therapy)
  • Remission, Spontaneous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: